Based on the ruling, products that are legal federally as well as at the state level can be reimbursed, which is a huge step forward, given that older policies prevented all cannabis-based substances from being reimbursed by insurance. However, we must be careful to take note of the nuances here; the ruling doesn’t treat cannabis as a primary medical treatment just yet but rather they are considered “specialized, non-primarily health-related benefits” by the Centers for Medicare and Medicaid Services (CMS).
The rise of the pot parent makes sense. Today's parents grew up skeptical of drug-war…
The data shows that approximately 4.4% of 8 million urine-based drug tests in the workplace…
Except the science keeps saying it isn't simple at all. The THC percentage is a…
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…